Unbiased Analysis of Today's Healthcare Issues
There is a lot of talk that Brexit will be a disaster. While I believe that much of this disaster talk is overblown, there are clear business implications. Pharmafile provides an example of how Brexit would affect a small pharmaceutical company conducting clinical trials in the UK. In the latter case, UK-based pharmaceutical companies with no other…
Will the European Medicines Agency (EMA) need to re-located after Brexit? According to a Reuters story, the answer is yes. The EMA is a London-based organization that approves treatments for all EU countries. As the UK leaves the EU, however, EMA is expected to have to relocate. 600 individuals work for EMA. More important is…
Although I believe that a lot of the pundits claims of economic downturns due to the Brexit are overblown, there are clearly many uncertainties to resolve. The Telegraph reports on how Brexit will affect doctors working in the UK. As a result of the country’s decision to leave the EU, health regulators may have to change the…